RCEL · Company research

Avita Medical, Inc. (RCEL): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 202612.99$358,851,262.98349712262.9812.3457943925233645——16.5354005612385955——

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.